The investment highlights GiantLeap Capital’s focus on growth equity in private and public special situations alongside leading global alternative asset managers and technology companies The transaction supports GiantLeap Capital’s thematic strategy focused on digital infrastructure technologies that are transforming critical industries NEW YORK, Jan. 5, 2024 /PRNewswire/ — GiantLeap Capital, a technology-focused private investment… Continue reading GiantLeap Capital Joins Intel Capital and DigitalBridge in Investing in Articul8, a spin-off of Intel’s business focused on Enterprise Generative AI
Category: Newswire
Free Digital Advisor Helps Students with Revamped FAFSA Form for College Financial Aid
PHILADELPHIA, Jan. 5, 2024 /PRNewswire/ — Wyatt®, the digital FAFSA advisor that has helped 30,000 students secure nearly $40 million in federal grant aid for college since 2019, is now fully updated to provide students with on-demand guidance to complete the revised Free Application for Federal Student Aid (FAFSA) form, Benefits Data Trust (BDT) announced… Continue reading Free Digital Advisor Helps Students with Revamped FAFSA Form for College Financial Aid
Transforming the future of retail: Pricer showcases digital in-store automation solutions at NRF
STOCKHOLM, Jan. 5, 2024 /PRNewswire/ — Pricer, the global leader in retail in-store automation and communication, will exhibit at the National Retail Federation (NRF)’s Big Show, taking place in New York from January 14 to 16. Exhibiting at booth #6457, Pricer solutions, recognized the world over by Tier 1 retail, will showcase its latest in-store… Continue reading Transforming the future of retail: Pricer showcases digital in-store automation solutions at NRF
BIO-TECHNE ANNOUNCES APPOINTMENT OF MATTHEW F. McMANUS AS PRESIDENT, DIAGNOSTICS AND GENOMICS SEGMENT
MINNEAPOLIS, Jan. 5, 2024 /PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH) today announced Matthew F. McManus has been appointed President, Diagnostics and Genomics Segment, effective January 8, 2024. Dr. McManus succeeds Kim Kelderman, who will become Bio-Techne’s Chief Executive Officer effective February 1, 2024. Dr. McManus has over two decades of experience as a senior life sciences… Continue reading BIO-TECHNE ANNOUNCES APPOINTMENT OF MATTHEW F. McMANUS AS PRESIDENT, DIAGNOSTICS AND GENOMICS SEGMENT
Nabla Raises $24M in Series B to Fuel Expansion of its Ambient AI Assistant to Transform Care Delivery
New financing, led by Cathay Innovation, will be used to expand capabilities and adoption of Nabla Copilot, the leading ambient AI assistant designed to alleviate the administrative burden placed on providers, and reduce clinician burnout. Launched in March 2023, Nabla Copilot has experienced rapid growth with +20,000 providers who have already adopted the solution for… Continue reading Nabla Raises $24M in Series B to Fuel Expansion of its Ambient AI Assistant to Transform Care Delivery
enCore Energy Provides Q4/23 ATM Quarterly Sales Update
NASDAQ:EUTSXV:EUencore uranium DALLAS, Jan. 5, 2024 /PRNewswire/ – enCore Energy Corp. (“enCore” or the “Company”) (NASDAQ: EU) (TSXV: EU) announced today, as required by the TSXV, that the Company issued a total of 7,579,563 common shares, between the period October 1, 2023 and December 31, 2023, under the at-the-market (ATM) controlled equity offering program. The… Continue reading enCore Energy Provides Q4/23 ATM Quarterly Sales Update
MAXST Unveils Cutting-Edge XR Metaverse Platform at CES 2024
LAS VEGAS, Jan. 5, 2024 /PRNewswire/ — MAXST Co., Ltd. (KRX:377030), a leader in metaverse technology, will showcase its revolutionary metaverse development platform, MAXVERSE, at CES 2024 in Las Vegas from January 9 to 12 at Booth 15863. MAXST will highlight MAXVERSE, an all-in-one metaverse platform designed to seamlessly blend the real world into the metaverse and… Continue reading MAXST Unveils Cutting-Edge XR Metaverse Platform at CES 2024
Genprex Provides Business Update and Outlook for 2024
Acclaim-1 Phase 2a and Acclaim-3 Phase 1 clinical studies opening for enrollment in January 2024 Poised for FDA guidance regarding diabetes gene therapy program in 2024 AUSTIN, Texas, Jan. 5, 2024 /PRNewswire/ — Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer… Continue reading Genprex Provides Business Update and Outlook for 2024
EndoQuest Robotics Partners with OMNIVISION to Equip Flexible Robotic System with Industry-leading Image Sensor
Novel flexible robotic system to offer best-in-class endoscopic visualization HOUSTON, Jan. 5, 2024 /PRNewswire/ — EndoQuest™ Robotics, Inc., a privately-held medical device company and pioneering leader in the development of innovative endoluminal robotic technologies, and OMNIVISION, a leading global developer of semiconductor solutions, including advanced digital imaging, and touch display technology, announced today a partnership to… Continue reading EndoQuest Robotics Partners with OMNIVISION to Equip Flexible Robotic System with Industry-leading Image Sensor
DELFI Diagnostics Appoints Susan Tousi as New Chief Executive Officer
Tousi brings expansive commercial strategic vision to accelerate FirstLook Lung U.S. market introduction; succeeds DELFI founder Victor Velculescu, M.D., Ph.D., who remains a director on the company’s Board BALTIMORE and PALO ALTO, Calif., Jan. 5, 2024 /PRNewswire/ — DELFI Diagnostics, Inc., a developer of accessible blood-based tests that deliver a new way to enhance cancer… Continue reading DELFI Diagnostics Appoints Susan Tousi as New Chief Executive Officer